0.135High0.135Low633Volume0.135Open0.135Pre Close85.46Turnover0.00%Turnover Ratio--P/E (Static)0Shares0.56052wk High--P/B0Float Cap0.00552wk Low--Dividend TTM0Shs Float0.560Historical High--Div YieldTTM0.00%Amplitude0.005Historical Low0.135Avg Price1Lot Size
On June 17, 2024, Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW), a company known for its innovative neurostimulation products, announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation device has been granted regulatory approval by the Brazilian Health Regulatory Agency (ANVISA). ANVISA is a regulatory body under the Br...
No comment yet